<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Bcl-x and c-Myc have an important role for the immune response by regulating the programmed cell <z:hpo ids='HP_0011420'>death</z:hpo> (<z:mpath ids='MPATH_3'>apoptosis</z:mpath>) of lymphocytes </plain></SENT>
<SENT sid="1" pm="."><plain>Dysfunction of these selection processes can lead to the development of malignant <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>The present study aimed at defining the differential expression of <z:mpath ids='MPATH_3'>apoptosis</z:mpath>, Bcl-x and c-Myc in <z:mpath ids='MPATH_458'>normal</z:mpath> and in malignant lymphoid tissues </plain></SENT>
<SENT sid="3" pm="."><plain>Follicular centre <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (FCL-F) and mantle cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MCL</z:e>) contained the lowest apoptotic indices (AIs), whereas Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) had the highest AIs </plain></SENT>
<SENT sid="4" pm="."><plain>The AIs correlated significantly with the growth rates of the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> and with the extent of Bcl-x expression </plain></SENT>
<SENT sid="5" pm="."><plain>Bcl-x was expressed in almost <z:hpo ids='HP_0000001'>all</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> cells, but in few <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> cells in FCL-F and in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MCL</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>c-Myc, in contrast, was found in the majority of the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> cells in FCL-F and in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MCL</z:e>, but not in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>Whereas the extent of Bcl-x expression correlated positively with the growth rates, an inverse correlation was observed between the percentages of c-Myc-positive <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> cells and the growth rates of the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>We conclude that <z:mpath ids='MPATH_458'>normal</z:mpath> and malignant lymphoid tissues have a distinct pattern of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and that expression of Bcl-x and c-Myc in B cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> is differentially regulated </plain></SENT>
</text></document>